Literature DB >> 28701739

Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.

Yukako Tatsumi1, Takayoshi Ohkubo1.   

Abstract

The prevalence of both hypertension and diabetes mellitus is increasing worldwide. Both diseases lead to severe complications such as cardiovascular and chronic kidney diseases, which increase the risk of death over a long period of time. Therefore, the prevention and aggravation of hypertension and diabetes mellitus are major challenges. Because few review articles have focused on the epidemiological perspective of hypertension and diabetes mellitus, we reviewed major observational studies mainly from Japan and from Western countries that have reported on the prevalence of hypertension and diabetes mellitus, the binominal risk of hypertension and diabetes mellitus, and the risk of their coexistence. Our investigation found that approximately 50% of diabetic patients had hypertension, and approximately 20% of hypertensive patients had diabetes mellitus. Those with either hypertension or diabetes mellitus had a 1.5- to 2.0-fold higher risk of having both conditions. These results were similar for both Japan and Western countries. Although comparing the results between Japan and Western countries was difficult because the risks were estimated using widely varying statistical analyses, it was revealed that the coexistence of hypertension and diabetes mellitus certainly increased the risk of complications regardless of the country. The definition, prevalence and medical treatment of hypertension and diabetes mellitus will change in the future. For early intervention based on the latest evidence to prevent severe complications, it is important to accumulate epidemiological knowledge of hypertension and diabetes mellitus and to update the evidence for both Japan and other countries.

Entities:  

Mesh:

Year:  2017        PMID: 28701739     DOI: 10.1038/hr.2017.67

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  74 in total

1.  Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling.

Authors:  Takehide Ogihara; Tomoichiro Asano; Katsuyuki Ando; Yuko Chiba; Hideyuki Sakoda; Motonobu Anai; Nobuhiro Shojima; Hiraku Ono; Yukiko Onishi; Midori Fujishiro; Hideki Katagiri; Yasushi Fukushima; Masatoshi Kikuchi; Noriko Noguchi; Hiroyuki Aburatani; Issei Komuro; Toshiro Fujita
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Physical activity and risk of hypertension: a meta-analysis of prospective cohort studies.

Authors:  Pengcheng Huai; Huanmiao Xun; Kathleen Heather Reilly; Yiguan Wang; Wei Ma; Bo Xi
Journal:  Hypertension       Date:  2013-09-30       Impact factor: 10.190

3.  Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II).

Authors:  Jan Cederholm; Soffia Gudbjörnsdottir; Björn Eliasson; Björn Zethelius; Katarina Eeg-Olofsson; Peter M Nilsson
Journal:  J Hypertens       Date:  2012-10       Impact factor: 4.844

Review 4.  Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis.

Authors:  Feng Wang; Lili Han; Dayi Hu
Journal:  Clin Chim Acta       Date:  2016-11-09       Impact factor: 3.786

5.  Glucose and the risk of hypertension in first-degree relatives of patients with type 2 diabetes.

Authors:  Mohsen Janghorbani; Fabrice Bonnet; Masoud Amini
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

6.  Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study.

Authors:  David Conen; Paul M Ridker; Samia Mora; Julie E Buring; Robert J Glynn
Journal:  Eur Heart J       Date:  2007-10-09       Impact factor: 29.983

7.  Excess risk of diabetes in persons with hypertension.

Authors:  Derek Weycker; Gregory A Nichols; Maureen O'Keeffe-Rosetti; John Edelsberg; Gabor Vincze; Zeba M Khan; Gerry Oster
Journal:  J Diabetes Complications       Date:  2008-05-29       Impact factor: 2.852

8.  Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80.

Authors:  S Kadowaki; T Okamura; A Hozawa; T Kadowaki; A Kadota; Y Murakami; K Nakamura; S Saitoh; Y Nakamura; T Hayakawa; Y Kita; A Okayama; H Ueshima
Journal:  Diabetologia       Date:  2008-01-16       Impact factor: 10.122

9.  Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database.

Authors:  Hans-Peter Hammes; Reinhard Welp; Hans-Peter Kempe; Christian Wagner; Erhard Siegel; Reinhard W Holl
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.

Authors: 
Journal:  Lancet       Date:  2016-11-16       Impact factor: 79.321

View more
  16 in total

1.  Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study.

Authors:  Yukiko Imai; Takumi Hirata; Shigeyuki Saitoh; Toshiharu Ninomiya; Yoshihiro Miyamoto; Hirofumi Ohnishi; Yoshitaka Murakami; Hiroyasu Iso; Sachiko Tanaka; Katsuyuki Miura; Akiko Tamakoshi; Michiko Yamada; Masahiko Kiyama; Hirotsugu Ueshima; Shizukiyo Ishikawa; Tomonori Okamura
Journal:  Hypertens Res       Date:  2020-07-03       Impact factor: 3.872

2.  Clinical implication of fasting glucose and systolic/diastolic blood pressure on the prevalence of periodontitis in non-diabetic and non-hypertensive adults using nationally representative data.

Authors:  Kyungdo Han; Jun-Beom Park
Journal:  Exp Ther Med       Date:  2018-06-07       Impact factor: 2.447

3.  Evaluation of Morphological Changes in Retinal Vessels in Type 1 Diabetes Mellitus Patients with the Use of Adaptive Optics.

Authors:  Wojciech Matuszewski; Katarzyna Gontarz-Nowak; Joanna M Harazny; Elżbieta Bandurska-Stankiewicz
Journal:  Biomedicines       Date:  2022-08-09

4.  Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells.

Authors:  Yoo Na Jang; Yong Jik Lee; Yoon Mi Han; Hyun Min Kim; Hong Seog Seo; Ji Hoon Jeong; Seung Yeon Park; Tae Woo Jung
Journal:  Yonsei Med J       Date:  2022-06       Impact factor: 3.052

5.  Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia.

Authors:  Yonas Akalu; Yitayeh Belsti
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-13       Impact factor: 3.168

6.  Efficacy and safety of traditional Chinese medicine injection with mecobalamin in treating diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis.

Authors:  Weihua Mai; Aisheng Wei; Xiaoxuan Lin; Funeng Wang; Jianhong Ye; Ping Chen
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

7.  Effects of Baduanjin on glucose and lipid metabolism in diabetic patients: A protocol for systematic review and meta-analysis.

Authors:  Qiaojun Ma; Hanzhang Li; Yinping Gao; Yalan Zou
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

8.  Prevalence and associated factors of hypertension among adults with diabetes mellitus in northern Sudan: a cross-sectional study.

Authors:  Omer Abdelbagi; Imad R Musa; Shaza M Musa; Salim A ALtigani; Ishag Adam
Journal:  BMC Cardiovasc Disord       Date:  2021-04-10       Impact factor: 2.298

9.  Hypertension and type 2 diabetes: lights and shadows about causality.

Authors:  GianLuca Colussi; Andrea Da Porto; Alessandro Cavarape
Journal:  J Hum Hypertens       Date:  2019-10-21       Impact factor: 3.012

10.  Control of Blood Pressure and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Hernando Vargas-Uricoechea; Manuel Felipe Cáceres-Acosta
Journal:  Open Med (Wars)       Date:  2018-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.